Lilly launches smallest single-dose vials of Zepbound for $399
By Patrick Wingrove (Reuters) -Eli Lilly said it has begun selling vials of the smallest, starter dose of its popular weight-loss drug Zepbound in the United States for $399 for a month on its direct-to-consumer website to try to increase supplies in the marketplace. Zepbound is typically sold in auto-injector pens, but with vials Lilly will eliminate that step and be able to get the drug to patients more quickly. The 2.5-milligram and 5-mg vials … Read more…